Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Agents”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00545558
What this trial is testing

Effects of Anti-HIV Drugs on the Hepatitis C Virus (HCV) in Adults Infected With Both HCV and HIV

Who this might be right for
Hepatitis CHIV Infections
University of Cincinnati 18
Not applicableStudy completedNCT05452616
What this trial is testing

Same-day Versus Rapid ART Initiation in HIV-positive Individuals Presenting With Symptoms of Tuberculosis

Who this might be right for
Human Immunodeficiency Virus (HIV) Infection
University Hospital, Basel, Switzerland 610
Not applicableStudy completedNCT00333892
What this trial is testing

Leukapheresis to Obtain Lymphocytes for Studies on Antiretroviral Naive HIV-infected Patients

Who this might be right for
Human Immunodeficiency Virus
Canadian Immunodeficiency Research Collaborative 220
Early research (Phase 1)Active Not RecruitingNCT05612178
What this trial is testing

Evaluate the Safety and Effects of Repeated Doses of 3BNC117-LS and 10-1074-LS on Persistent Viral Reservoirs in People Living With HIV and on Suppressive Antiretroviral Therapy

Who this might be right for
HIV-1
National Institute of Allergy and Infectious Diseases (NIAID) 105
Testing effectiveness (Phase 2)Study completedNCT02946047
What this trial is testing

The Effect of Ixazomib on the Latent HIV Reservoir

Who this might be right for
Human Immunodeficiency Virus (HIV)
Mayo Clinic 17
Post-approval studies (Phase 4)Study completedNCT00192660
What this trial is testing

HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)

Who this might be right for
HIV-Associated Lipodystrophy SyndromeCardiovascular Disease
Kirby Institute 80
Not applicableActive Not RecruitingNCT07665060
What this trial is testing

HIV Antibody Increases Following Viral Rebound in People Receiving Antiretroviral Therapy

Who this might be right for
HIV
NYU Langone Health 6,100
Large-scale testing (Phase 3)UnknownNCT02588820
What this trial is testing

Impact of Extremely Early Antiretroviral Therapy to Reduce VIral REservoir and Induce Functional CURE of HIV-1 Infection

Who this might be right for
HIV Infections
David Garcia Cinca 15
Testing effectiveness (Phase 2)UnknownNCT03602690
What this trial is testing

Evaluation of Third-line cART Regimen in Cambodia (3DICAM)

Who this might be right for
HIV/AIDS
ANRS, Emerging Infectious Diseases 54
Testing effectiveness (Phase 2)Study completedNCT00056797
What this trial is testing

Therapeutic HIV Vaccine and Interleukin-2 to Increase the Immune System's Response to HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 92
Not applicableStudy completedNCT00923624
What this trial is testing

Patient Portal to Support Treatment Adherence

Who this might be right for
Antiretroviral Medication Adherence
Kaiser Permanente 304
Not applicableActive Not RecruitingNCT07703748
What this trial is testing

Long-Term Real-World Evidence Study to Evaluate Effectiveness, Persistence, Adherence, Safety and Tolerability of Long-acting Cabotegravir Plus Rilpivirine.

Who this might be right for
Human Immunodeficiency Virus Infection (HIV)HIV-1 Infection in Adults
FUNDACIÓN HOSPITAL UNIVERSITARIO INFANTA LEONOR Y DEL HOSPITAL UNIVERSITARIO DEL SURESTE 3,346
Not applicableStudy completedNCT03137797
What this trial is testing

Cohort of Patients Naive of Antiretroviral Treatment at Enrollment

Who this might be right for
HIV Infection
ANRS, Emerging Infectious Diseases 800
Not applicableActive Not RecruitingNCT06500013
What this trial is testing

WhatsApp Intervention to Assess the Effect of Messages in Adherence to Antiretrovirals in Young People With HIV in Peru

Who this might be right for
HIV
Universidad Peruana Cayetano Heredia 131
Not applicableStudy completedNCT01296373
What this trial is testing

Explore Reconstitution of Immunity in Patients With Advanced HIV-1-infection

Who this might be right for
HIV Immune Restoration
Kirby Institute 53
Early research (Phase 1)Study completedNCT00796770
What this trial is testing

Vaccination of HIV-1 Infected Patients With Dendritic Cells in Addition to Antiretroviral Treatment - (DALIA Trial)

Who this might be right for
HIV
Baylor Research Institute 19
Testing effectiveness (Phase 2)Study completedNCT00034866
What this trial is testing

Dose Ranging Trial of Tipranavir/Ritonavir in Treatment-Experienced HIV Infected Individuals

Who this might be right for
HIV Infections
Boehringer Ingelheim 165
Not applicableStudy completedNCT02116751
What this trial is testing

Frequency and Clinical Significance of Renal and Bone Toxicity in HIV-infected Patients

Who this might be right for
Renal Toxicity
Asociacion para el Estudio de las Enfermedades Infecciosas 306
Large-scale testing (Phase 3)Study completedNCT00887653
What this trial is testing

Changes in Lipids and Safety of Raltegravir in HIV+ Patients With Hyperlipidemia While on Current Standard Therapy

Who this might be right for
HIVHyperlipidemiaHypertriglyceridemia+1 more
The Miriam Hospital 20
Early research (Phase 1)Study completedNCT00099671
What this trial is testing

Safety of Interleukin-7 in HIV Infected People Currently Taking Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 25
Next Page